Historical record - last NADAC publication: 5/23/2013
Product Information
AMPHOTERICIN B 50 MG VIAL is a generic product labeled by XGen Pharmaceuticals DJB, Inc., priced at $20.8740 per EA under NDC 39822105505. Its NADAC has been published 29 times since Nov 28, 2013.
Strength
50 mg/10mL
Manufacturer
XGen Pharmaceuticals DJB, Inc.NDC
39822105505
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
5/23/2013
Active Ingredients
AMPHOTERICIN BApproval Type
Generic (ANDA)
FDA Application
ANDA063206On Market Since
4/29/1992
Pharmacological Classes
Price Statistics
The NADAC for AMPHOTERICIN B 50 MG VIAL has been published 29 times since Nov 28, 2013, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $20.8740 per EA |
|---|---|
| All-time high | $20.8740 (Jun 11, 2014) |
| All-time low | $20.8740 (Nov 28, 2013) |
| Median price | $20.8740 |
| Average price | $20.8740 |
| Largest weekly change | 0.0% (Dec 5, 2013) |
| Weeks tracked | 29 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Amphotericin B market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of AMPHOTERICIN B 50 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for AMPHOTERICIN B 50 MG VIAL, manufactured by XGen Pharmaceuticals DJB, Inc., is $20.8740 per EA (NDC 39822105505), effective Jun 11, 2014.
How has the price of AMPHOTERICIN B 50 MG VIAL changed over time?
Over the history we have for it, the NADAC for AMPHOTERICIN B 50 MG VIAL has held within roughly two percent of its current level. It has been tracked across 29 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for AMPHOTERICIN B 50 MG VIAL?
Since Nov 28, 2013, the NADAC for AMPHOTERICIN B 50 MG VIAL has ranged from a low of $20.8740 (Nov 28, 2013) to a high of $20.8740 (Jun 11, 2014), with a median of $20.8740 per EA.
Are there cheaper alternatives to AMPHOTERICIN B 50 MG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of AMPHOTERICIN B 50 MG VIAL, so no direct lower-cost alternative is listed.
Who manufactures AMPHOTERICIN B 50 MG VIAL?
AMPHOTERICIN B 50 MG VIAL (NDC 39822105505) is labeled by XGen Pharmaceuticals DJB, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification